News
Company updates, scientific milestones, product developments, and announcements from vivoVerse.
vivoVerse awarded NIH/NIEHS grant to develop novel approaches for developmental neurotoxicity testing
July 9, 2024
vivoVerse awarded SBIR Phase II grant from the NIEHS
August 5, 2023
vivoVerse cofounders publish single-cell isolation method using femtosecond laser microdissection (fs-LM)
May 3, 2023
Meeting report: A successful and enjoyable time at SOT2023 in Nashville for vivoVerse
April 6, 2023
vivoVerse at the Society of Toxicology Annual Meeting in Nashville
March 2, 2023
vivoVerse moves into new HQ
May 5, 2021
Newormics resumes operations
August 20, 2020
vivoVerse Announces Intent to Grant Utility Patent on the vivoChip® by the European Patent Office
August 5, 2020
vivoVerse awarded SBIR Phase II grant from the NIMH
July 8, 2020
COVID-19 UPDATE
March 27, 2020
Newormics launches new vivoChips for early stage worms
October 14, 2019
DDNews features Newormics in their latest issue in a special report on drug screening
August 10, 2019
Newormics at the 2019 UK C. elegans meeting
July 30, 2019
Newormics awarded an SBIR Phase I grant from the NIEHS
July 9, 2019
Newormics at the 2019 International C. elegans Conference
June 20, 2019
Newormics selected for the NIH I-Corps
June 18, 2019
